Mey UJ - Search Results

1

Salvage Chemotherapy with R-DHAP in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma.

Schirmbeck NG, Mey UJ, Olivieri A, Ko YD, Kaiser U, Flieger D, Witzens-Harig M, Schmidt-Wolf IG. Schirmbeck NG, et al. Among authors: mey uj. Cancer Invest. 2016 Sep 13;34(8):361-72. doi: 10.1080/07357907.2016.1212062. Epub 2016 Sep 16. Cancer Invest. 2016. PMID: 27635469

2

Dexamethasone, high-dose cytarabine, and cisplatin in combination with rituximab as salvage treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma.

Mey UJ, Orlopp KS, Flieger D, Strehl JW, Ho AD, Hensel M, Bopp C, Gorschlüter M, Wilhelm M, Birkmann J, Kaiser U, Neubauer A, Florschütz A, Rabe C, Hahn C, Glasmacher AG, Schmidt-Wolf IG. Mey UJ, et al. Cancer Invest. 2006 Oct;24(6):593-600. doi: 10.1080/07357900600814490. Cancer Invest. 2006. PMID: 16982464 Clinical Trial.

3

DHAP in combination with rituximab vs DHAP alone as salvage treatment for patients with relapsed or refractory diffuse large B-cell lymphoma: a matched-pair analysis.

Mey UJ, Olivieri A, Orlopp KS, Rabe C, Strehl JW, Gorschlueter M, Hensel M, Flieger D, Glasmacher AG, Schmidt-Wolf IG. Mey UJ, et al. Leuk Lymphoma. 2006 Dec;47(12):2558-66. doi: 10.1080/10428190600926572. Leuk Lymphoma. 2006. PMID: 17169800 Clinical Trial.

4

Sequential high-dose chemotherapy with autologous stem cell support in patients with limited-stage small cell lung cancer.

Ziske C, Gorschlüter M, Mey U, Offergeld R, Glasmacher A, Schmidt-Wolf IG. Ziske C, et al. Anticancer Res. 2002 Nov-Dec;22(6B):3723-6. Anticancer Res. 2002. PMID: 12552983 Clinical Trial.

5

High-dose chemotherapy followed by autologous stem cell transplantation as first-line therapy in aggressive non-Hodgkin's lymphoma: a meta-analysis.

Strehl J, Mey U, Glasmacher A, Djulbegovic B, Mayr C, Gorschlüter M, Ziske C, Schmidt-Wolf IG. Strehl J, et al. Haematologica. 2003 Nov;88(11):1304-15. Haematologica. 2003. PMID: 14607760

6

Long-term survival of a patient with small cell lung cancer after nine lines of chemotherapy and radiation.

Gressner O, Popp H, Mey U, Friedrichs N, Strehl J, Sauerbruch T, Schmidt-Wolf IG, Gorschlüter M. Gressner O, et al. Onkologie. 2008 Sep;31(8-9):469-72. doi: 10.1159/000142396. Epub 2008 Aug 15. Onkologie. 2008. PMID: 18787355

7

Weekly docetaxel in patients with pretreated metastatic breast cancer: a phase II trial.

Mey U, Gorschlüter M, Ziske C, Kleinschmidt R, Glasmacher A, Schmidt-Wolf IG. Mey U, et al. Anticancer Drugs. 2003 Mar;14(3):233-8. doi: 10.1097/00001813-200303000-00007. Anticancer Drugs. 2003. PMID: 12634618 Clinical Trial.

8

Sequential Hodgkin's and non-Hodgkin's lymphoma in non-immunocompromised patients.

Khristi J, Mey U, Kirfel J, Schmidt-Wolf IG, Gütgemann I. Khristi J, et al. Ann Hematol. 2013 Nov;92(11):1565-7. doi: 10.1007/s00277-013-1742-0. Epub 2013 Apr 5. Ann Hematol. 2013. PMID: 23558907 Review. No abstract available.

9

Hairy cell leukemia: short review, today's recommendations and outlook.

Maevis V, Mey U, Schmidt-Wolf G, Schmidt-Wolf IG. Maevis V, et al. Blood Cancer J. 2014 Feb 14;4(2):e184. doi: 10.1038/bcj.2014.3. Blood Cancer J. 2014. PMID: 24531447 Free PMC article.

10

Pegfilgrastim as hematopoietic support for dose-dense chemoimmunotherapy with R-CHOP-14 as first-line therapy in elderly patients with diffuse large B cell lymphoma.

Mey UJ, Maier A, Schmidt-Wolf IG, Ziske C, Forstbauer H, Banat GA, Reber M, Strehl JW, Gorschlueter M. Mey UJ, et al. Support Care Cancer. 2007 Jul;15(7):877-84. doi: 10.1007/s00520-006-0201-z. Support Care Cancer. 2007. PMID: 17235504 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

86 results

Search Page

Filters